Chemiesynth Board Approves Share Capital Increase & Preference Share Issuance

Chemiesynth (Vapi) Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the standalone un-audited financial results for the quarter ended June 30, 2026. The board also approved a significant increase in the company's authorized share capital from ₹3.25 Crores to ₹18.25 Crores. This includes the issuance of up to 1,50,00,000 Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis, aggregating up to ₹15 Crores, with a 5% annual dividend rate. The company also scheduled its 40th Annual General Meeting for September 30, 2026.